CE / CME
In this on-demand webcast, Roger S. McIntyre, MD, FRCPC, defines the distinctive mechanisms of action and pharmacokinetic characteristics of novel and emerging therapeutic agents for schizophrenia, highlighting their efficacy, safety data, and adverse event profiles. He also explains the clinical utility of these novel treatments to address current unmet needs of patients with schizophrenia.
Psychologists: 1.00 APA CE Credit
Social Workers: 1.00 ASWB ACE CE Credit
Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit
Nurse Practitioners/Nurses: 1.00 Nursing contact hour
Pharmacists: 1.00 contact hour (0.1 CEUs)
Physicians: maximum of 1.00 AMA PRA Category 1 Credit™
Released: June 12, 2025
Expiration: June 11, 2026
Share
Provided by Clinical Care Options, LLC
Supported by an educational grant from Bristol-Myers Squibb.
Bristol Myers Squibb
This activity is intended for healthcare professionals caring for patients with schizophrenia including psychiatrists, physicians, nurse practitioners, physician associates, registered nurses, pharmacists, social workers, and psychologists.
The goal of this activity is to provide sustained education that will improve healthcare professionals’ knowledge, competence, and performance in adopting the latest best practices to optimize care of patients with schizophrenia.
Upon completion of this activity, participants should be able to:
Define the distinctive mechanisms of action and pharmacokinetic characteristics of novel and emerging therapeutic agents for schizophrenia that extend beyond traditional antidopaminergic approaches
Assess efficacy and safety data, adverse events of novel and emerging treatments for schizophrenia
Explain the clinical utility of novel antipsychotics to address unmet needs of current schizophrenia treatments
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Primary AuthorJoseph F. Goldberg, MD: consultant/advisor/speaker: AbbVie, Alkermes, Alvogen, Axsome, Bristol Myers Squibb, Genomind, Intra-Cellular, Neumora, Otsuka, Sunovion.
Roger S. McIntyre, MD, FRCPC: consultant/advisor/speaker: AbbVie, Alkermes, Atai Life Sciences, Axsome, Bausch Health, Biogen, Boehringer Ingelheim, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neurawell, Neurocrine, New Bridge, Neumora, Novo Nordisk, Otsuka, Pfizer, Purdue, Sage, Sanofi, Sunovion, Takeda, Viatris.
The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose except Michael Asbach, DMSc, PA-C, as noted below:
Michael Asbach, DMSc, PA-C: consultant/advisor/speaker: AbbVie, Axsome Therapeutics, Bristol Myers Squibb, Johnson & Johnson, Intra-Cellular, Neurocrine Biosciences, Otsuka, Sage/Biogen, Teva.
Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 12, 2025, through June 11, 2026:
Login or Sign Up for an account by clicking at the top of this page.
Read the target audience, learning objectives, and faculty disclosures.
View and study the content in its entirety.
Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.
Continuing Pharmacy Education
CCO designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-25-222-H01-P
Type of Activity: Application
Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Physician Associate Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until June 11, 2026. PAs should only claim credit commensurate with the extent of their participation.
Psychologist Continuing Education
Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
This activity offers 1 continuing education credit for psychologists.
Social Work Continuing Education
As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1 clinical continuing education credit.
ABMS Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Beyond Dopamine: Innovations in Schizophrenia Treatment and Addressing Unmet Needs has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
CME Passport
The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.